Prospective observational multicenter study of patients with AH and CKD markers in Kazakhstan (PROGRESS-CKD)

Trial Identifier:	D1843R00359
Sponsor:	AstraZeneca
Start Date:	January 2025
Primary Completion Date:	April 2026
Study Completion Date:	April 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Kazakhstan	Temirlanovka village, Kazakhstan

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.